These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 11154268)

  • 21. Identification of mutations (D128G, H141L) in the liver arginase gene of patients with hyperargininemia.
    Vockley JG; Tabor DE; Kern RM; Goodman BK; Wissmann PB; Kang DS; Grody WW; Cederbaum SD
    Hum Mutat; 1994; 4(2):150-4. PubMed ID: 7981719
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
    Truong B; Allegri G; Liu XB; Burke KE; Zhu X; Cederbaum SD; Häberle J; Martini PGV; Lipshutz GS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21150-21159. PubMed ID: 31501335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular basis of phenotypic variation in patients with argininemia.
    Uchino T; Snyderman SE; Lambert M; Qureshi IA; Shapira SK; Sansaricq C; Smit LM; Jakobs C; Matsuda I
    Hum Genet; 1995 Sep; 96(3):255-60. PubMed ID: 7649538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
    Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
    Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A role for PPARα in the regulation of arginine metabolism and nitric oxide synthesis.
    Guelzim N; Mariotti F; Martin PG; Lasserre F; Pineau T; Hermier D
    Amino Acids; 2011 Oct; 41(4):969-79. PubMed ID: 21063737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.
    Gau CL; Rosenblatt RA; Cerullo V; Lay FD; Dow AC; Livesay J; Brunetti-Pierri N; Lee B; Cederbaum SD; Grody WW; Lipshutz GS
    Mol Ther; 2009 Jul; 17(7):1155-63. PubMed ID: 19367256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency.
    Sin YY; Price PR; Ballantyne LL; Funk CD
    Sci Rep; 2017 May; 7(1):2585. PubMed ID: 28566761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role and control of arginine levels in arginase 1 deficiency.
    Diaz GA; Bechter M; Cederbaum SD
    J Inherit Metab Dis; 2023 Jan; 46(1):3-14. PubMed ID: 36175366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of enzyme-loaded erythrocytes in in-vitro correction of arginase-deficient erythrocytes in familial hyperargininemia.
    Adriaenssens K; Karcher D; Lowenthal A; Terheggen HG
    Clin Chem; 1976 Mar; 22(3):323-6. PubMed ID: 1253407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of novel ARG1 mutations causing hyperargininemia and correlation with arginase I activity in erythrocytes.
    Carvalho DR; Brand GD; Brum JM; Takata RI; Speck-Martins CE; Pratesi R
    Gene; 2012 Nov; 509(1):124-30. PubMed ID: 22959135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Argocytes containing enzyme nanoparticles reduce toxic concentrations of arginine in the blood.
    Kaminsky YG; Kosenko EA
    Bull Exp Biol Med; 2012 Jul; 153(3):406-8. PubMed ID: 22866323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal cholestasis: an uncommon presentation of hyperargininemia.
    Gomes Martins E; Santos Silva E; Vilarinho S; Saudubray JM; Vilarinho L
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S503-6. PubMed ID: 21229317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperargininemia with arginase deficiency.
    Cederbaum SD; Shaw KN; Spector EB; Verity MA; Snodgrass PJ; Sugarman GI
    Pediatr Res; 1979 Jul; 13(7):827-33. PubMed ID: 481955
    [No Abstract]   [Full Text] [Related]  

  • 34. Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.
    Asrani KH; Cheng L; Cheng CJ; Subramanian RR
    RNA Biol; 2018; 15(7):914-922. PubMed ID: 29923457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic study of human arginase deficiency.
    Grody WW; Klein D; Dodson AE; Kern RM; Wissmann PB; Goodman BK; Bassand P; Marescau B; Kang SS; Leonard JV
    Am J Hum Genet; 1992 Jun; 50(6):1281-90. PubMed ID: 1598908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of arginase II alters prostate tumor formation in TRAMP mice.
    Mumenthaler SM; Rozengurt N; Livesay JC; Sabaghian A; Cederbaum SD; Grody WW
    Prostate; 2008 Oct; 68(14):1561-9. PubMed ID: 18663728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone down-regulates ornithine aminotransferase gene and up-regulates arginase II and ornithine decarboxylase genes for polyamines synthesis in the murine kidney.
    Levillain O; Diaz JJ; Blanchard O; Déchaud H
    Endocrinology; 2005 Feb; 146(2):950-9. PubMed ID: 15539552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic studies of arginase in tissues of normal human adult and arginase-deficient patients.
    Spector EB; Rice SC; Cederbaum SD
    Pediatr Res; 1983 Dec; 17(12):941-4. PubMed ID: 6419196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginase-1 deficiency.
    Sin YY; Baron G; Schulze A; Funk CD
    J Mol Med (Berl); 2015 Dec; 93(12):1287-96. PubMed ID: 26467175
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of arginase alters circulating and tissue amino acids and guanidino compounds and affects neuromotor behavior in mice.
    de Jonge WJ; Marescau B; D'Hooge R; De Deyn PP; Hallemeesch MM; Deutz NE; Ruijter JM; Lamers WH
    J Nutr; 2001 Oct; 131(10):2732-40. PubMed ID: 11584097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.